https://www.oncologynurseadvisor.com Sat, 14 Oct 2023 02:11:46 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png https://www.oncologynurseadvisor.com 32 32 https://www.oncologynurseadvisor.com/home/cancer-types/prostate-cancer/intensified-adt-for-recurrent-high-risk-prostate-cancer-beneficial/ Mon, 06 Mar 2023 15:20:00 +0000 https://www.oncologynurseadvisor.com/?p=105380 Intensified ADT with apalutamide, with or without abiraterone plus prednisone, for 52 weeks prolonged PSA progression-free survival compared with ADT alone among men with high-risk biochemically recurrent prostate cancer following radical prostatectomy. ]]> https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/amazons-virtual-health-clinic-raises-patient-privacy-issues/ Wed, 08 Feb 2023 15:40:00 +0000 https://www.renalandurologynews.com/?p=111529 How the retail giant will use the sensitive medical data it collects is among the concerns.]]> https://www.oncologynurseadvisor.com/home/cancer-types/prostate-cancer/metastasis-directed-therapy-beneficial-in-oligometastatic-prostate-cancer/ Wed, 23 Nov 2022 15:20:00 +0000 https://www.oncologynurseadvisor.com/?p=103419 Investigators reported findings from the first randomized trial to evaluate the use of metastasis-directed therapy with hormone therapy in patients with oligometastatic prostate cancer.]]> https://www.oncologynurseadvisor.com/home/departments/radiation-and-your-patient/sabr-quite-safe-for-treating-oligometastases/ Fri, 18 Nov 2022 15:20:00 +0000 https://www.oncologynurseadvisor.com/?p=103278 Investigators characterized the toxicity of stereotactic body radiotherapy for oligometastases from predominantly prostate, colorectal, breast, and lung cancer.]]> https://www.oncologynurseadvisor.com/home/cancer-types/prostate-cancer/higher-psa-screening-rates-tied-to-lower-metastatic-prostate-cancer-incidence/ Thu, 03 Nov 2022 14:30:00 +0000 https://www.oncologynurseadvisor.com/?p=103028 Each 10% increase in PSA screening rates was significantly associated with a 9% decrease in the metastatic prostate cancer rates, according to a study of VA medical centers.]]> https://www.oncologynurseadvisor.com/home/cancer-types/kidney-cancer/adaptive-nivolumab-plus-ipilimumab-improves-outcomes-in-mrcc/ Wed, 12 Oct 2022 14:20:00 +0000 https://www.oncologynurseadvisor.com/?p=102632 Final results from the TITAN-RCC trial demonstrate improvements in objective response rates compared with nivolumab monotherapy.]]> https://www.oncologynurseadvisor.com/home/cancer-types/prostate-cancer/prostate-cancer-ctc-psma-status-could-guide-therapy/ Wed, 05 Oct 2022 14:40:00 +0000 https://www.oncologynurseadvisor.com/?p=102508 PSMA expression on circulating tumor cells in men with mCRPC increases upon disease progression despite treatment with novel antiandrogens.]]> https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/report-ransomware-attacks-rise-sharply/ Wed, 10 Aug 2022 14:20:00 +0000 https://www.renalandurologynews.com/?p=106840 Ransomware attacks now account for 25% of all data breaches, according to Verizon’s 2022 Data Breach Investigation Report.]]> https://www.oncologynurseadvisor.com/home/cancer-types/breast-cancer/clinical-trials-black-patients-lack-access-interest-metastatic-breast-cancer/ Tue, 07 Jun 2022 14:15:00 +0000 https://www.oncologynurseadvisor.com/?p=99975 More than 80% of Black survey respondents said they were somewhat or very likely to consider enrolling in a clinical trial.]]> https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/fda-proposes-recommendations-to-improve-medical-device-security/ Mon, 06 Jun 2022 14:00:00 +0000 https://www.renalandurologynews.com/?p=105879 The agency has issued proposed draft recommendations to guide incorporation of cybersecurity protections into medical devices at the time of manufacture.]]>